CSPC Total Current Liabilities from 2010 to 2024

300765 Stock   28.51  0.27  0.94%   
CSPC Innovation's Total Current Liabilities is increasing over the years with slightly volatile fluctuation. Total Current Liabilities is expected to dwindle to about 429.1 M. Total Current Liabilities is the total amount of liabilities that CSPC Innovation Pharmaceutical is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2017-06-30
Previous Quarter
925.5 M
Current Value
876.9 M
Quarterly Volatility
183.5 M
 
Covid
Check CSPC Innovation financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSPC Innovation's main balance sheet or income statement drivers, such as Tax Provision of 82.2 M, Net Interest Income of 68.5 M or Interest Income of 69.2 M, as well as many indicators such as . CSPC financial statements analysis is a perfect complement when working with CSPC Innovation Valuation or Volatility modules.
  
This module can also supplement various CSPC Innovation Technical models . Check out the analysis of CSPC Innovation Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in CSPC Stock

CSPC Innovation financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Innovation security.